RESPIRATORY
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
To reduce the risk of exacerbation and death from asthma at all levels, including in patients with mild asthma
|
|
|
To provide consistent messaging regarding the goals of asthma treatment, including prevention of exacerbations, across all levels of asthma
|
|
|
To prevent patients from becoming SABA dependent from an early stage
|
|
|
To increase the use of SABA
|
Detailed explanation-1: -Guidelines recommend close monitoring of patients who overuse SABA and avoiding over-reliance on SABA monotherapy. SABA overuse is associated with increased risk of asthma exacerbations and mortality, increased use of health services and negative physical and mental health outcomes.
Detailed explanation-2: -Landmark Changes in the 2019 GINA Asthma Strategy Report Instead, GINA recommends that all adults and adolescents with asthma should receive either symptom-driven (for mild asthma) or daily inhaled anti-inflammatory controller treatment, to reduce their risk of serious exacerbations and to control symptoms.
Detailed explanation-3: -The 2019 Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated with inhaled corticosteroids taken daily or as needed; this improves symptoms and outcomes, even in those with mild disease.